TORI 104 Pre-Surgical Dasatinib

Summary

This study will examine the anti-tumor activity, safety and tolerability of dasatinib in adjuvant breast cancer patients in a pre-surgical setting.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications